Vomidon 10 mg Tablets
PDF Leaflet Revision Date: 26 October 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Short term relief of insomnia due to anxiety.
Dosage (summary)
1 tablet (5 mg) before retiring; may increase to 10 mg if necessary.
Special Populations
- Elderly patients
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Avoid in pregnancy and breastfeeding; may cause dependence in infants.
Key Drug Interactions
- Alcohol
- Opioids
- Antipsychotics
- CNS depressants
Contraindications
- Hypersensitivity to nitrazepam
- Myasthenia gravis
- Severe respiratory insufficiency
- Sleep apnoea
- Severe hepatic insufficiency
- Pregnancy
- Children
Common side effects
- Drowsiness
- Confusion
- Fatigue
- Headache
- Dizziness
Counselling Points
- Avoid alcohol
- Do not drive or operate machinery
- Taper off dosage gradually
- Monitor for signs of respiratory depression
Serious warnings
- Risk of dependence
- Withdrawal symptoms
- Caution in respiratory insufficiency
- Risk of sedation with opioids
Important Disclaimer
The Vomidon 10 mg Tablets professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
